NEW PRODUCTS
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 21238 | Seralutinib | 1619931-27-9 | 98% Min. |  |
| Seralutinib, also known as PK-10571 and GB002, is a Novel Inhaled Pdgfr Kinase Inhibi | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||
| 20471 | FHD-286 | 2671128-05-3 | ≧98.0% |  |
| FHD-286 is an oral, small-molecule, selective, allosteric inhibitor of BRG1 and BRM i | ||||
| 24017 | AMG-193 | 2790567-82-5 | 98.62%; EE 98.28% |  |
| AMG-193 is an oral, small-molecule, methylthioadenosine-cooperative inhibitor of the | ||||
| 20638 | ATH434 mesylate | 2387898-69-1 | ≧98.0% |  |
| ATH434, is an oral agent designed to inhibit the aggregation of pathological proteins | ||||
| 20549 | STC-15 | 2648257-56-9 | ≧98.0% |  |
| STC-15 is a first-in-class inhibitor of RNA modification and is the first ever RNA me | ||||
| 23122601 | Navacaprant ( BTRX-335140 ) | 2244614-14-8 | ≧98.0% | _2244614-14-8.png) |
| Navacaprant (NMRA-335140, BTRX-140) is an oral, selective, reversible, small-molecule | ||||
| 2073103 | Remibrutinib ( LOU064 ) | 1787294-07-8 | 98% Min. |  |
| Remibrutinib ( LOU064 ) is a Potent and Highly Selective Covalent Inhibitor of Bruton | ||||
| 90731 | GDC-0810 ( Brilanestrant , ARN-810 ) | 1365888-06-7 | ≧98.0% | _1365888-06-7.png) |
| GDC-0810 (Brilanestrant, ARN-810, RG6046) is a selective estrogen receptor degrader ( | ||||
| 102703 | AZD-8835 | 1620576-64-8 | ≧98.0% |  |
| AZD8835 is a potent and selective inhibitor of PI3Kalpha and PI3Kdelata with excellen | ||||
| 611902 | PF-04979064 | 1220699-06-8 | ≧98.0% |  |
| PF-04979064 is a potent and selective PI3K/mTOR dual kinase inhibitor with an IC(50) | ||||
| 6111110 | Nastorazepide | 209219-38-5 | 98% |  |
| Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative | ||||